Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter ...

Meanwhile, the company's board declared an interim dividend of Rs 4 per share for FY26, The company has fixed 8 August 2025, ...

Mumbai :Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

Aurobindo Pharma Ltd. reported a 10.3 per cent year-on-year (YoY) decline in consolidated net profit to Rs 824.2 crore in Q1 ...

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

Domestic equity benchmarks halted a two-day losing streak amid buying in IT, energy and auto shares on Monday, though selling ...

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Stocks including Paytm, Aditya Infotech, Bosch, Laxmi India Finance, Aurobindo Pharma, DLF, Bharti Airtel, Siemens Energy and ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...